New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

The list of health conditions that benefit from the GLP-1 weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound, continues to grow. The drugs are already approved to lower the ...

Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his ...